Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3916 results

Sort By:

CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children

Study ID: NCT07023744
Start Date: 2025-10-01
End Date: 2028-03-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Placebo

CBD Isolate

CBD that

Sponsor

University of Manitoba

Source: clinicaltrials.gov

Share:
Add to list

Muscle Activity of the Gastrocnemius and Soleus Muscles by Surface Electromyography.

Study ID: NCT06953401
Start Date: 2025-09-01
End Date: 2025-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Muscle contraction protocol for electromyographic assessment

Sponsor

University of Extremadura

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Clinical Wear and Surface Roughness of Partial Restorations Produced by Additive and Subtractive Manufacturing Methods: A Split-Mouth Randomized Controlled Clinical Trial

Study ID: NCT07057401
Start Date: 2025-09-20
End Date: 2027-06-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

CAD-CAM Manufactured Crowns

3D Printed Crowns

Sponsor

Husna selinaay

Source: clinicaltrials.gov

Share:
Add to list

Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users

Study ID: NCT06594068
Start Date: 2025-08-29
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

16

Intervention / Treatment

Anifrolumab

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

The Effect Of Enamel Matrix Protein On Gingival Tissue Thickness. A Randomized Controlled Trial

Study ID: NCT07053969
Start Date: 2025-08-01
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Enamel Matrix Derivative

Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Study ID: NCT06696768
Start Date: 2026-01-23
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Infinite

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Enormity

Fluorouracil

Leucovorin calcium

Magnetic Resonance Imaging

Oxaliplatin

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Pain Neuroscience Education for Middle School Students

Study ID: NCT06869369
Start Date: 2025-09-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

57

Intervention / Treatment

Turkish PNE4Kids

Sponsor

Kutahya Health Sciences University

Source: clinicaltrials.gov

Share:
Add to list

Normobaric Oxygen Therapy in Colorectal Cancer Patients

Study ID: NCT06946004
Start Date: 2025-11-01
End Date: 2028-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

254

Intervention / Treatment

Normobaric oxygen therapy

Normobaric oxygen therapy

Sponsor

4th Military Clinical Hospital with Polyclinic, Poland

Source: clinicaltrials.gov

Share:
Add to list

The SUNRISE Project is Dedicated to Enhancing Primary Cancer Prevention Among Adolescents in Europe by Leveraging Innovative Digital Tools and Methodologies. SmartCoach, Developed by Swiss Research Institute for Public Health and Addiction (ISGF), is a Mobile Phone-based Life-skills Training Program

Study ID: NCT06922201
Start Date: 2025-09
End Date: 2028-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3500

Intervention / Treatment

SmartCoach

Sponsor

Biocruces Bizkaia Health Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Study ID: NCT07028801
Start Date: 2025-07-31
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

3000

Intervention / Treatment

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Freeze-dried human rabies vaccine (human diploid cells)

Sponsor

Ningbo Rongan Biological Pharmaceutical Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list